At a glance
ClinicalIndex Comparison RecordN/ACompleted· 687 enrolled
Drug / intervention
Neupro®drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non-Interventional Study (NIS) in Patients With Restless Legs Syndrome (RLS) to Assess the Effectiveness and Safety of Neupro® in Daily Practise
In Brief
An observational study evaluating Neupro® for Idiopathic Restless Legs Syndrome. Completed, enrolled 687 participants across 80 sites.
Detailed Summary
This non-interventional observational study is designed to gain data for Neupro® in restless legs syndrome (RLS) under real life conditions in line with the summary of product characteristics (SmPC) related to effectiveness, tolerability and switching practice from other dopaminergic drugs as well as titration schemes.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsIdiopathic Restless Legs Syndrome
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2010
Enrollment StartMay 2010
Primary CompletionJul 2011
TodayJul 2026
First PostedApr 30, 2010
Enrollment StartMay 1, 2010
Primary CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 16.2 years ago
Interventions
Neupro®drug
Neupro® is the exposure/intervention of interest in this non-interventional study.